Clinical Trials Browser

Phase NA × Uveal Melanoma × 30 days × Clear all

NCT07364474 2026-03-11

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Phase NA Recruiting

Uveal Melanoma, Neoplasm Metastasis